Correlation Between AstraZeneca PLC and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Eli Lilly and, you can compare the effects of market volatilities on AstraZeneca PLC and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Eli Lilly.

Diversification Opportunities for AstraZeneca PLC and Eli Lilly

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between AstraZeneca and Eli is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Eli Lilly go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Eli Lilly

Considering the 90-day investment horizon AstraZeneca PLC is expected to generate 2.14 times less return on investment than Eli Lilly. But when comparing it to its historical volatility, AstraZeneca PLC ADR is 1.34 times less risky than Eli Lilly. It trades about 0.09 of its potential returns per unit of risk. Eli Lilly and is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  63,259  in Eli Lilly and on January 24, 2024 and sell it today you would earn a total of  9,874  from holding Eli Lilly and or generate 15.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC ADR  vs.  Eli Lilly and

 Performance 
       Timeline  
AstraZeneca PLC ADR 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC ADR are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, AstraZeneca PLC may actually be approaching a critical reversion point that can send shares even higher in May 2024.
Eli Lilly 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and Eli Lilly

The main advantage of trading using opposite AstraZeneca PLC and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind AstraZeneca PLC ADR and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios